Pure Global
NCT06212414

Mind Programme for Women With Breast Cancer (Nationwide Coverage)

Mind Programme for Women With Breast Cancer: A Randomized Controlled Trial Testing the Programme´s Cost-effectiveness and Efficacy in Changing Psychological and Biological Outcomes (Nationwide Coverage)
University of Coimbra·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Breast Cancer Female
Drug/Device/Intervention
Mind Programme
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of Coimbra
Location
Coimbra, Portugal
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2023
End date
Dec 01, 2025
Enrollment
153 participants
Primary outcome

Change from baseline cancer-specific quality of life at post-treatment and 6-month follow-up

Summary

The purpose of this research project is to optimize the Mind programme for women with breast
 cancer, taking into consideration the results from its pilot study, and to testits efficacy
 and cost-effectiveness through a 3-arm randomized controlled trial

ICD-10 classifications
Malignant neoplasm: Breast, unspecifiedMalignant neoplasm of breastMalignant neoplasm of breastCarcinoma in situ of breast, unspecifiedPersonal history of malignant neoplasm of breast
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06212414
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06212414 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Coimbra and is currently Recruiting. The study focuses on Breast Cancer Female. Target enrollment is 153 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.